Cross-Border Healthtech Merger Targets America's $50 Billion Nutrition Care Gap with AI-Dietitian Hybrid Model
India's Healthify and US-based Berry Street combine forces to scale insurance-reimbursed nutrition services for the booming GLP-1 medication market.

India-based healthtech startup Healthify has merged with US nutrition care firm Berry Street in an all-stock transaction designed to crack one of digital health's toughest challenges: delivering AI-powered nutrition services that insurance companies will actually pay for. The deal unites Healthify's decade of AI development and 45 million user base with Berry Street's network of over 2,000 credentialed registered dietitians operating across all 50 US states.
The combined entity will operate under the Berry Street brand in the United States while maintaining Healthify's name in international markets. Tushar Vashisht, Healthify's founder, and Noah Kotlove, Berry Street's founder, will serve as co-CEOs of the merged organization. Financial terms and valuation details were not disclosed.
Betting on the GLP-1 Support Market
The merger arrives as demand for nutrition services surges alongside the explosive growth of GLP-1 medications for weight management. Both companies have positioned themselves to support patients using these anti-obesity drugs, which require ongoing dietary guidance to maximize effectiveness and minimize side effects.
Berry Street already provides nutrition support for GLP-1 users in the US market, while Healthify launched anti-obesity medicine support programs in India in 2025. The companies identified this segment as a primary growth driver for the combined platform, which aims to blend Healthify's AI nutrition assistant "Ria"—developed over 10 years—with Berry Street's insurance-credentialed clinical workforce.
According to the companies, insurance reimbursement represents a major obstacle to scaling dietitian-led services in the US market. Berry Street's existing payor relationships and credentialing infrastructure provide the regulatory foundation that Healthify's AI technology alone could not access independently.
From Consumer Wellness to Clinical Integration
The strategic pivot reflects broader shifts in digital health business models. Healthify, which raised approximately $150 million from Khosla Ventures, Blume Ventures, and Chiratae Ventures since its 2012 founding, built its reputation as a consumer wellness platform. Berry Street, which secured $50 million in 2025 from Northzone, Sofina, and FJ Labs, focused on insurance-integrated clinical nutrition from the outset.
The merger creates a hybrid care delivery model that uses AI to extend dietitian capacity—potentially addressing workforce constraints while maintaining the clinical credibility required for insurance reimbursement. Patients may receive daily AI-driven guidance supplemented by periodic consultations with human registered dietitians, a structure designed to reduce wait times and costs for evidence-based nutrition care.
Global Expansion Strategy
While the US market represents the primary growth focus, the combined company plans expansion into the Middle East, Western Europe, and Australia. The dual-brand strategy allows the organization to leverage Berry Street's clinical credentialing in regulated markets while maintaining Healthify's consumer brand recognition in regions with different healthcare payment structures.
For healthcare providers, the platform offers a potential solution to metabolic health management capacity constraints by pairing AI patient engagement tools with credentialed expertise. For health tech companies, the deal underscores that technology alone remains insufficient for penetration of regulated healthcare segments—payor relationships and clinical networks function as essential competitive moats in insurance-dependent markets.
Sources
Companies in this article
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.